{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:02:44Z","timestamp":1771351364341,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-13-00031-P"],"award-info":[{"award-number":["22-13-00031-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11095-025-03976-3","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T19:12:10Z","timestamp":1765307530000},"page":"235-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimorphism in riluzole salicylate: screening, crystal structures and solution thermodynamics"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-2277","authenticated-orcid":false,"given":"Alexander P.","family":"Voronin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-7588","authenticated-orcid":false,"given":"Anna G.","family":"Ramazanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-303X","authenticated-orcid":false,"given":"Anna V.","family":"Vologzhanina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-5244","authenticated-orcid":false,"given":"German L.","family":"Perlovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"3976_CR1","doi-asserted-by":"publisher","unstructured":"Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II. Lancet. 1996;347:1425\u201331.\u00a0https:\/\/doi.org\/10.1016\/s0140-6736(96)91680-3.","DOI":"10.1016\/s0140-6736(96)91680-3"},{"key":"3976_CR2","doi-asserted-by":"publisher","unstructured":"Andrews JA, Jackson CE, Heiman-Patterson TD, Bettica P, Brooks BR, Pioro EP. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:509\u201318.\u00a0https:\/\/doi.org\/10.1080\/21678421.2020.1771734.","DOI":"10.1080\/21678421.2020.1771734"},{"key":"3976_CR3","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/archneur.60.11.1601","volume":"60","author":"BS Russman","year":"2003","unstructured":"Russman BS, Iannaccone ST, Samaha FJ. A phase 1 trial of riluzole in spinal muscular atrophy. Arch Neurol. 2003;60:1601\u20133.","journal-title":"Arch Neurol"},{"key":"3976_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/2012.4.AOSPINE1259","volume":"17","author":"MG Fehlings","year":"2012","unstructured":"Fehlings MG, Wilson JR, Frankowski RF, Toups EG, Aarabi B, Harrop JS, Shaffrey CI, Harkema SJ, Guest JD, Tator CH, Burau KD, Johnson MW, Grossman RG. Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN phase I clinical trial. J Neurosurg Spine. 2012;17:151\u20136.","journal-title":"J Neurosurg Spine"},{"key":"3976_CR5","doi-asserted-by":"publisher","unstructured":"Weisbrod LJ, Nilles-Melchert TT, Bergjord JR, Surdell DL. Safety and efficacy of riluzole in traumatic spinal cord injury: a systematic review with meta-analyses. Neurotrauma Rep. 2024;5:117\u201327.\u00a0https:\/\/doi.org\/10.1089\/neur.2023.0114.","DOI":"10.1089\/neur.2023.0114"},{"key":"3976_CR6","doi-asserted-by":"publisher","unstructured":"Golmohammadi M, Mahmoudian M, Hasan EK, Alshahrani SH, Romero-Parra RM, Malviya J, et al. Neuroprotective effects of riluzole in Alzheimer\u2019s disease: a comprehensive review. Fundam Clin Pharmacol. 2024;38:225\u201337.\u00a0https:\/\/doi.org\/10.1111\/fcp.12955.","DOI":"10.1111\/fcp.12955"},{"key":"3976_CR7","doi-asserted-by":"crossref","unstructured":"Blyufer A, Lhamo S, Tam C, Tariq I, Thavornwatanayong T, Mahajan SS. Riluzole: a neuroprotective drug with potential as a novel anti-cancer agent (Review). Int J Oncol. 2021;59:95.","DOI":"10.3892\/ijo.2021.5275"},{"key":"3976_CR8","first-page":"100363","volume":"10","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen G, Li M, Li M, Xie D, Luo Z. Development of long-acting riluzole transdermal patch against amyotrophic lateral sclerosis: mechanistic insights into polyglyceryl-3 dioleate-enhanced drug release and skin permeation. Int Pharm. 2025;10:100363.","journal-title":"Int Pharm"},{"key":"3976_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cpdd.1168","volume":"12","author":"J Wymer","year":"2023","unstructured":"Wymer J, Apple S, Harrison A, Hill BA. Pharmacokinetics, bioavailability, and swallowing safety with riluzole oral film. Clin Pharmacol Drug Dev. 2023;12:57\u201364.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"3976_CR10","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1021\/acs.cgd.6b01894","volume":"17","author":"PK Mondal","year":"2017","unstructured":"Mondal PK, Rao V, Mittapalli S, Chopra D. Exploring solid state diversity and solution characteristics in a fluorine-containing drug Riluzole. Cryst Growth Des. 2017;17:1938\u201346. https:\/\/doi.org\/10.1021\/acs.cgd.6b01894.","journal-title":"Cryst Growth Des"},{"key":"3976_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1021\/acs.cgd.7b01514","volume":"18","author":"B Yadav","year":"2018","unstructured":"Yadav B, Balasubramanian S, Chavan RB, Thipparaboina R, Naidu VGM, Shastri NR. Hepatoprotective cocrystals and salts of Riluzole: prediction, synthesis, solid state characterization, and evaluation. Cryst Growth Des. 2018;18:1047\u201361. https:\/\/doi.org\/10.1021\/acs.cgd.7b01514.","journal-title":"Cryst Growth Des"},{"key":"3976_CR12","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1039\/C8CE00283E","volume":"20","author":"PK Mondal","year":"2018","unstructured":"Mondal PK, Rao V, Chopra D. Capturing the metastable state in the spontaneous and reversible single-crystal-to-single-crystal phase transition of riluzolium oxalate. CrystEngComm. 2018;20:2079\u201383. https:\/\/doi.org\/10.1039\/C8CE00283E.","journal-title":"CrystEngComm"},{"key":"3976_CR13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1107\/S2053229619008325","volume":"75","author":"PK Mondal","year":"2019","unstructured":"Mondal PK, T A, Rao V, Chopra D. Crystal structure analysis of the biologically active drug mol-ecule riluzole and riluzolium chloride. Acta Crystallogr Sect E Struct Rep Online. 2019;75:1084\u20139.","journal-title":"Acta Crystallogr Sect E Struct Rep Online"},{"key":"3976_CR14","first-page":"3591","volume":"25","author":"SP Thomas","year":"2019","unstructured":"Thomas SP, Kumar V, Alhameedi K, Guru Row TN. Non-classical synthons: supramolecular recognition by S\u22c5\u22c5\u22c5O chalcogen bonding in molecular complexes of Riluzole. Chemistry (Easton). 2019;25:3591\u20137.","journal-title":"Chemistry (Easton)"},{"key":"3976_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/pharmaceutics15030878","volume":"15","author":"AP Voronin","year":"2023","unstructured":"Voronin AP, Surov AO, Churakov AV, Vener MV. Supramolecular organization in salts of Riluzole with dihydroxybenzoic acids\u2014the key role of the mutual arrangement of OH groups. Pharmaceutics. 2023;15:878.","journal-title":"Pharmaceutics"},{"key":"3976_CR16","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1021\/acs.cgd.4c01278","volume":"24","author":"AP Voronin","year":"2024","unstructured":"Voronin AP, Ramazanova AG, Churakov AV, Vologzhanina AV, Kulikova ES, Perlovich GL. Virtual screening, polymorphism, and formation thermodynamics study of Riluzole multicomponent crystals with dihydroxybenzoic acids. Cryst Growth Des. 2024;24:9773\u201389.","journal-title":"Cryst Growth Des"},{"key":"3976_CR17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.5c00792","author":"AP Voronin","year":"2025","unstructured":"Voronin AP, Ramazanova AG, Drozd KV, Churakov AV, Perlovich GL. Hydrogen bond architecture, thermal anisotropy, and dissolution performance of Riluzole multicomponent crystals. Cryst Growth Des. 2025. https:\/\/doi.org\/10.1021\/acs.cgd.5c00792.","journal-title":"Cryst Growth Des"},{"key":"3976_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.5c00089","author":"AR Al Ahmad","year":"2025","unstructured":"Al Ahmad AR, Maris T, Wuest JD. Hiding in plain sight: polymorphs of Riluzole. Cryst Growth Des. 2025. https:\/\/doi.org\/10.1021\/acs.cgd.5c00089.","journal-title":"Cryst Growth Des"},{"key":"3976_CR19","doi-asserted-by":"publisher","unstructured":"Srinivas S, Wali AR, Pham MH. Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature. Neurosurg Focus. 2019;46:E6.https:\/\/doi.org\/10.3171\/2019.1.focus18596.","DOI":"10.3171\/2019.1.focus18596"},{"key":"3976_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.lfs.2016.02.072","volume":"154","author":"B Thrash-Williams","year":"2016","unstructured":"Thrash-Williams B, Karuppagounder SS, Bhattacharya D, Ahuja M, Suppiramaniam V, Dhanasekaran M. Methamphetamine-induced dopaminergic toxicity prevented owing to the neuroprotective effects of salicylic acid. Life Sci. 2016;154:24\u20139.","journal-title":"Life Sci"},{"key":"3976_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1107\/S0021889802019878","volume":"36","author":"A Coelho","year":"2003","unstructured":"Coelho A. Indexing of powder diffraction patterns by iterative use of singular value decomposition. J Appl Crystallogr. 2003;36:86\u201395. https:\/\/doi.org\/10.1107\/S0021889802019878.","journal-title":"J Appl Crystallogr"},{"key":"3976_CR22","doi-asserted-by":"publisher","unstructured":"Coelho A. TOPAS and TOPAS-Academic: an optimization program integrating computer algebra and crystallographic objects written in C++. J Appl Cryst. 2018;51(1):210-8. https:\/\/doi.org\/10.1107\/S1600576718000183.","DOI":"10.1107\/S1600576718000183"},{"key":"3976_CR23","first-page":"43","volume":"32","author":"AA Coelho","year":"2005","unstructured":"Coelho AA, Kern A. Discussion of the indexing algorithms within TOPAS. CPD Newsletter. 2005;32:43\u20135.","journal-title":"CPD Newsletter"},{"key":"3976_CR24","unstructured":"Bruker AXS. Topas V4: General profile and structure analysis software for powder diffraction data. User's Manual. Karlsruhe:BrukerAXS; 2008."},{"key":"3976_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1107\/S002188980000248X","volume":"33","author":"A Coelho","year":"2000","unstructured":"Coelho A. Whole-profile structure solution from powder diffraction data using simulated annealing. J Appl Crystallogr. 2000;33:899\u2013908. https:\/\/doi.org\/10.1107\/S002188980000248X.","journal-title":"J Appl Crystallogr"},{"key":"3976_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1107\/S0365110X67000234","volume":"22","author":"HM Rietveld","year":"1967","unstructured":"Rietveld HM. Line profiles of neutron powder-diffraction peaks for structure refinement. Acta Crystallogr. 1967;22:151\u20132.","journal-title":"Acta Crystallogr"},{"key":"3976_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1107\/S0021889869006558","volume":"2","author":"H Rietveld","year":"1969","unstructured":"Rietveld H. A profile refinement method for nuclear and magnetic structures. J Appl Crystallogr. 1969;2:65\u201371. https:\/\/doi.org\/10.1107\/S0021889869006558.","journal-title":"J Appl Crystallogr"},{"key":"3976_CR28","doi-asserted-by":"crossref","unstructured":"Dovesi R, Erba A, Orlando R, Zicovich\u2010Wilson CM, Civalleri B, Maschio L, R\u00e9rat M, Casassa S, Baima J, Salustro S, Kirtman B. Quantum\u2010mechanical condensed matter simulations with CRYSTAL. Wiley Interdiscip Rev: Comput Mol Sci. 2018;8(4):e1360. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/wcms.1360.","DOI":"10.1002\/wcms.1360"},{"key":"3976_CR29","doi-asserted-by":"crossref","unstructured":"McKinnon JJ, Jayatilaka D, Spackman MA. Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces. Chem Commun. 2007(37):3814-6.","DOI":"10.1039\/b704980c"},{"key":"3976_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cplett.2011.03.055","volume":"507","author":"I Mata","year":"2011","unstructured":"Mata I, Alkorta I, Espinosa E, Molins E. Relationships between interaction energy, intermolecular distance and electron density properties in hydrogen bonded complexes under external electric fields. Chem Phys Lett. 2011;507:185\u20139.","journal-title":"Chem Phys Lett"},{"key":"3976_CR31","doi-asserted-by":"publisher","unstructured":"Melikova SM, Voronin AP, Panek J, Frolov NE, Shishkina AV, Rykounov AA, Tretyakov PY, Vener MV. Interplay of pi-stacking and inter-stacking interactions in two-component crystals of neutral closed-shell aromatic compounds: periodic DFT study. RSC Adv. 2020;10:27899\u201327910.\u00a0https:\/\/doi.org\/10.1039\/d0ra04799f.","DOI":"10.1039\/d0ra04799f"},{"key":"3976_CR32","first-page":"446","volume":"22","author":"JDH Donnay","year":"1937","unstructured":"Donnay JDH, Harker D. A new law of crystal morphology extending the law of Bravais. Am Mineral. 1937;22:446\u201367.","journal-title":"Am Mineral"},{"key":"3976_CR33","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1021\/acs.cgd.9b00379","volume":"19","author":"AOL \u00c9vora","year":"2019","unstructured":"\u00c9vora AOL, Bernardes CES, Piedade MFM, Concei\u00e7\u00e3o ACL, Minas da Piedade ME. Energetics of Glycine Cocrystal or Salt Formation with Two Regioisomers: Fumaric Acid and Maleic Acid. Cryst Growth Des. 2019;19:5054\u201364. https:\/\/doi.org\/10.1021\/acs.cgd.9b00379.","journal-title":"Cryst Growth Des"},{"key":"3976_CR34","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1021\/acs.cgd.9b00781","volume":"19","author":"AO Surov","year":"2019","unstructured":"Surov AO, Manin AN, Voronin AP, Boycov DE, Magdysyuk OV, Perlovich GL. New pharmaceutical cocrystal forms of Flurbiprofen: structural, physicochemical, and thermodynamic characterization. Cryst Growth Des. 2019;19:5751\u201361. https:\/\/doi.org\/10.1021\/acs.cgd.9b00781.","journal-title":"Cryst Growth Des"},{"key":"3976_CR35","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1039\/C6CE00931J","volume":"18","author":"AO Surov","year":"2016","unstructured":"Surov AO, Solanko KA, Bond AD, Bauer-Brandl A, Perlovich GL. Cocrystals of the antiandrogenic drug bicalutamide: screening, crystal structures, formation thermodynamics and lattice energies. CrystEngComm. 2016;18:4818\u201329. https:\/\/doi.org\/10.1039\/C6CE00931J.","journal-title":"CrystEngComm"},{"key":"3976_CR36","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1039\/C9CE00124G","volume":"21","author":"D Ahuja","year":"2019","unstructured":"Ahuja D, Sv\u00e4rd M, Rasmuson \u00c5C. Investigation of solid\u2013liquid phase diagrams of the sulfamethazine\u2013salicylic acid co-crystal. CrystEngComm. 2019;21:2863\u201374. https:\/\/doi.org\/10.1039\/C9CE00124G.","journal-title":"CrystEngComm"},{"key":"3976_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF01197379","volume":"72","author":"A Burger","year":"1979","unstructured":"Burger A, Ramberger R. On the polymorphism of pharmaceuticals and other molecular crystals. I: Theory of thermodynamic rules. Microchim Acta. 1979;72:259\u201371.","journal-title":"Microchim Acta"},{"key":"3976_CR38","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/jps.2600840812","volume":"84","author":"L Yu","year":"1995","unstructured":"Yu L. Inferring thermodynamic stability relationship of polymorphs from melting data. J Pharm Sci. 1995;84:966\u201374.","journal-title":"J Pharm Sci"},{"key":"3976_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122140","volume":"13","author":"FJ Acebedo-Mart\u00ednez","year":"2021","unstructured":"Acebedo-Mart\u00ednez FJ, Alarc\u00f3n-Payer C, Frontera A, Barbas R, Prohens R, Di Crisci M, Dom\u00ednguez-Mart\u00edn A, G\u00f3mez-Morales J, Choquesillo-Lazarte D. Novel polymorphic cocrystals of the non-steroidal anti-inflammatory drug niflumic acid: expanding the pharmaceutical landscape. Pharmaceutics. 2021;13: 2140.","journal-title":"Pharmaceutics"},{"key":"3976_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1021\/op300241f","volume":"17","author":"A Newman","year":"2013","unstructured":"Newman A. Specialized solid form screening techniques. Org Process Res Dev. 2013;17:457\u201371. https:\/\/doi.org\/10.1021\/op300241f.","journal-title":"Org Process Res Dev"},{"key":"3976_CR41","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1021\/acs.molpharmaceut.5b00629","volume":"12","author":"AO Surov","year":"2015","unstructured":"Surov AO, Manin AN, Churakov AV, Perlovich GL. New solid forms of the antiviral drug Arbidol: crystal structures, thermodynamic stability, and solubility. Mol Pharm. 2015;12:4154\u201365.","journal-title":"Mol Pharm"},{"key":"3976_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/acs.cgd.3c00949","volume":"24","author":"AN Manin","year":"2023","unstructured":"Manin AN, Boycov DE, Simonova OR, Drozd KV, Volkova TV, Perlovich GL. How molecular packing affects the thermodynamic parameters of cocrystal formation: the case of Carbamazepine cocrystals. Cryst Growth Des. 2023;24:252\u201361.","journal-title":"Cryst Growth Des"},{"key":"3976_CR43","doi-asserted-by":"publisher","unstructured":"Vasilev NA, Perlovich GL. Thermodynamic characteristics of multi-component crystals: experimental evaluation, prediction and relationship with crystal parameters. J Mol Liq. 2024;411:125793.\u00a0https:\/\/doi.org\/10.1016\/j.molliq.2024.125793.","DOI":"10.1016\/j.molliq.2024.125793"},{"key":"3976_CR44","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJM196706082762308","volume":"276","author":"HW Davenport","year":"1967","unstructured":"Davenport HW. Salicylate damage to the gastric mucosal barrier. N Engl J Med. 1967;276:1307\u201312.","journal-title":"N Engl J Med"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03976-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03976-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03976-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:05:35Z","timestamp":1771347935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03976-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["3976"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03976-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}